05/22/2024
3:38 PM | BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:39 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:39 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:40 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:04 AM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:16 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:17 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
LIAU LINDA M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/15/2024
8:18 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
JOHNSON B KRISTINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:19 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Klein Matthew B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:19 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:20 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:21 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FALLON LYNNETTE C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:17 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
3:05 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form DEF 14A | |
04/02/2024
3:44 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:51 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:52 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:17 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
3:39 PM | BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:40 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:40 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:41 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:05 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:00 AM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/28/2024
3:05 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 424B5 | |
02/23/2024
5:12 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:30 PM | Bigger Capital, LLC (Filed by)
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
| Form SC 13G | |
01/03/2024
7:51 PM | BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:51 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:52 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
7:52 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
10:57 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
10:56 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
10:56 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
11:15 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form EFFECT | |
11/13/2023
8:22 AM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/12/2023
1:44 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
11:41 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
11:41 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
LEAKED: Jeff Bezos' $330 Million Gamble (Ad) Did you know that 3 simple words are disrupting a $62.7 billion market?
"Blood Brain Barrier"
Seems innocent enough. Here's how you could invest alongside them >>> |
10/03/2023
11:42 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
11:41 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:37 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
4:25 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
3:48 PM | ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
3:32 PM | BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
11:28 AM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:46 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:46 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:46 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:47 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:47 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:47 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:47 PM | BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:41 PM | ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
PTC THERAPEUTICS, INC. (Filed by)
| Form SC 13D/A | |
06/13/2023
4:02 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:02 PM | ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:02 PM | BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
7:23 AM | ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
PTC THERAPEUTICS, INC. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
